Bibliography

PinPoint eBook (Open Access Government)

November 2022

1.       Giannakeas ,V., Kotsopoulos, J., Cheung MC. et al. Analysis of Platelet Count and New Cancer Diagnosis Over a 10-Year Period. JAMA Netw Open. 2022;5(1):e2141633. o https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2787932 

2.       Nøst TH, Alcala K, Urbarova I, Byrne KS, Guida F, Sandanger TM, Johansson M. Systemic inflammation markers and cancer incidence in the UK Biobank. Eur J Epidemiol. 2021 Aug;36(8):841-848. o https://pubmed.ncbi.nlm.nih.gov/34036468/ 

3.       Yang, D., Li, H., Sun, X. et al. Clinical usefulness of high levels of C-reactive protein for diagnosing epithelial ovarian cancer. Sci Rep 10, 20056 (2020). o https://www.nature.com/articles/s41598-020-77167-y 

4.       Inoguchi, T., Nohara, Y., Nojiri, C. et al. Association of serum bilirubin levels with risk of cancer development and total death. Sci Rep 11, 13224 (2021). o https://www.nature.com/articles/s41598-021-92442-2 

5.       Funston, G., Hamilton, W., Abel, G., Crosbie, E.J., Rous, B. and Walter, F.M., 2020. The diagnostic performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: A population-based cohort study. PLoS medicine, 17(10), p.e1003295.   https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1003295 

6.       Pérez-Ibave DC, Burciaga-Flores CH, Elizondo-Riojas MÁ. Prostate-specific antigen (PSA) as a possible biomarker in non-prostatic cancer: A review. Cancer Epidemiology. 2018; 54:48-55 o https://www.sciencedirect.com/science/article/pii/S1877782118300936 

7.       Black, M.H., Giai, M., Ponzone, R., Sismondi, P., Yu, H. and Diamandis, E.P., 2000. Serum total and free prostate-specific antigen for breast cancer diagnosis in women. Clinical cancer research, 6(2), pp.467-473. ohttps://aacrjournals.org/clincancerres/article/6/2/467/287977/Serum-Total-and-Free-Prostate-specific-Antigen-for 

8.       Klein, E.A., Richards, D., Cohn, A., Tummala, M., Lapham, R., Cosgrove, D., Chung, G., Clement, J., Gao, J., Hunkapiller, N. and Jamshidi, A., 2021. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Annals of Oncology, 32(9), pp.1167-1177. o https://www.sciencedirect.com/science/article/pii/S0923753421020469 

9.       Cohen, J.D., Li, L., Wang, Y., Thoburn, C., Afsari, B., Danilova, L., Douville, C., Javed, A.A., Wong, F., Mattox, A. and Hruban, R.H., 2018. Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science, 359(6378), pp.926-930.  https://www.science.org/doi/abs/10.1126/science.aar3247 

10.    Wan, N., Weinberg, D., Liu, T.Y., Niehaus, K., Ariazi, E.A., Delubac, D., Kannan, A., White, B., Bailey, M., Bertin, M. and Boley, N., 2019. Machine learning enables detection of early-stage colorectal cancer by whole-genome sequencing of plasma cell-free DNA. BMC cancer, 19(1), pp.1-10.  https://bmccancer.biomedcentral.com/articles/10.1186/s12885-019-6003-8 

11.    Lee, J., Kim, HC., Kim, ST. et al. Multimodal circulating tumor DNA (ctDNA) colorectal neoplasia detection assay for asymptomatic and early-stage colorectal cancer (CRC). https://ascopubs.org/doi/abs/10.1200/JCO.2021.39.15_suppl.3536